Get started
Author

Aurél György Prósz

Observed names: A. Prosz, Aurel György Prósz, Aurel Prosz, Aurél Prósz
ORCID: 0000-0002-8494-6340
Observed ORCID: 0000-0002-8494-6340
OpenAlex ID: A5113072885
Unconstrained generation of synthetic antibody–antigen structures to guide machine learning methodology for antibody specificity prediction
2022 · Philippe A. Robert, Rahmad Akbar, et al. · Nature Computational Science · 69
PDF
Biologically informed deep learning for explainable epigenetic clocks
2024 · Aurel Prosz, Orsolya Pipek, et al. · Scientific Reports · 47
PDF
Comparative Assessment of Diagnostic Homologous Recombination Deficiency–Associated Mutational Signatures in Ovarian Cancer
2021 · Zsofia Sztupinszki, Miklos Diossy, et al. · Clinical Cancer Research · 38
PDF
Detection of Molecular Signatures of Homologous Recombination Deficiency in Bladder Cancer
2021 · Judit Börcsök, Miklos Diossy, et al. · Clinical Cancer Research · 27
Label-free optical biosensor for on-line monitoring the integrated response of human B cells upon the engagement of stimulatory and inhibitory immune receptors
2016 · Istvan Kurucz, Beatrix Peter, et al. · Sensors and Actuators B Chemical · 24
Intensity interrogation near cutoff resonance for label-free cellular profiling
2016 · Yousef Nazirizadeh, Volker Behrends, et al. · Scientific Reports · 21
PDF
ADP-ribosylome analysis reveals homogeneous DNA-damage-induced serine ADP-ribosylation across wild-type and BRCA-mutant breast cancer cell lines
2024 · Holda Awah Anagho, Meeli Mullari, et al. · Cell Reports · 14
PDF
Mutational signature-based identification of DNA repair deficient gastroesophageal adenocarcinomas for therapeutic targeting
2024 · Aurel Prosz, Pranshu Sahgal, et al. · npj Precision Oncology · 13
PDF
Nucleotide excision repair deficiency is a targetable therapeutic vulnerability in clear cell renal cell carcinoma
2023 · Aurel Prosz, Haohui Duan, et al. · Scientific Reports · 12
PDF
Replicative stress in gastroesophageal cancer is associated with chromosomal instability and sensitivity to DNA damage response inhibitors
2023 · Pranshu Sahgal, Deepa T. Patil, et al. · iScience · 9
Frequent CHD1 deletions in prostate cancers of African American men is associated with rapid disease progression
2024 · Miklos Diossy, Viktoria Tisza, et al. · npj Precision Oncology · 6
PDF
Dextran-based Hydrogel Layers for Biosensors
2020 · Andras Saftics, Barbara Türk, et al. · Springer eBooks · 6
Are tumor-associated carbohydrates the missing link between the gut microbiome and response to immune checkpoint inhibitor treatment in cancer?
2024 · Zoltan Szallasi, Aurel Prosz, et al. · OncoImmunology · 5
RNAi Screen Identifies MTA1 as an Epigenetic Modifier of Differentiation Commitment in Human HSPCs
2022 · Kristijonas Žemaitis, Agatheeswaran Subramaniam, et al. · Experimental Hematology · 3
PDF
A multimodal AI biomarker PATH-ORACLE improves prediction of recurrence in stage I lung adenocarcinoma
2026 · O. Kilim, O. Pipek, et al. · Immuno-Oncology Technology · 2
PDF
Generation of a comprehensive epigenomic atlas in clear cell renal cell carcinoma informs kidney cancer progression and heritability
2026 · Sarah Abou Alaiwi, Elio Adib, et al. · Cell Reports · 2
Polymerase theta expression is correlated with proliferative capacity but not with DNA repair deficiency status in solid tumors
2025 · Zsofia Sztupinszki, Regina Fiam, et al. · npj Precision Oncology · 2
PDF
Subclonal CHD1 deletion is more frequent in African American prostate cancers and associated with rapid disease progression and limited levels of homologous recombination deficiency
2021 · Miklos Diossy, Viktoria Tisza, et al. · medRxiv · 2
PDF
Genomic characterization of therapy-associated polyposis reveals an alkylating mutational signature from prior treatment
2026 · Yashika Parashar, Zsofia Sztupinszki, et al. · Journal of Clinical Investigation · 1
PDF
ADP-ribosylome analysis reveals homogeneous DNA-damage-induced serine ADP-ribosylation across wild-type and BRCA-mutant breast cancer cell lines
2024 · Holda Awah Anagho, Meeli Mullari, et al. · Cell Reports · 1
PDF
Author Correction: Mutational signature-based identification of DNA repair deficient gastroesophageal adenocarcinomas for therapeutic targeting
2024 · Aurel Prosz, Pranshu Sahgal, et al. · npj Precision Oncology · 1
3020 – Rna-interference Screen Identifies Mta1 as a Regulator of Human Hematopoietic Stem and Progenitor Cells
2022 · Kristijonas Zemaitis, Aurel Prosz, et al. · Experimental Hematology · 1
Nucleotide excision repair deficiency identified by mutational signatures is associated with cisplatin response in triple-negative breast cancer
2026 · Zsofia Sztupinszki, Judit Börcsök, et al. · npj Breast Cancer
Identification of an ERCC2 Mutation–Associated Mutational Signature of Nucleotide Excision Repair Deficiency in Targeted Panel Sequencing Data
2026 · Olivera Stojkova, Judit Börcsök, et al. · JCO Precision Oncology
PDF
Zero-shot biological reasoning with open-weights large language models reproduces CRISPR screen based prediction of synthetic lethal interactions
2026 · Aurel Prosz, Zsofia Sztupinszki, et al. · bioRxiv (Cold Spring Harbor Laboratory)
PDF
Works count: 52
Citation count: 306
H-index: 9
I10-index: 9
Year
Topic
Type